Adam Besvinick
Adam Besvinick is a guest on the Care Shift podcast with host Sathvik Bilakanti. This episode covers various aspects of venture investing in early-stage companies, focusing on healthcare and AI. They discuss strategies for founders, investor perspectives, and market dynamics in the tech landscape.
What did Adam teach us?
- 01
A pass from one investor isn't a definitive judgment on a company's potential. Smart investors can be wrong, and conviction in a company's vision is key, especially at the pre-seed stage where much is still uncertain.
- 02
Achieving strong distribution is a crucial differentiator, particularly as product creation becomes easier with AI. Founders with deep industry expertise and existing customer networks have a significant advantage in sales and market entry.
- 03
Data moats are effective when they involve unique, hard-to-replicate data acquisition methods and lead to network effects. Simply scraping public data isn't enough; look for data that compounds in value as more customers use the product.
- 04
Building a business entirely around selling data to large AI labs carries significant risk. While it can provide revenue, these large players can quickly enter your market, making it important for founders to diversify their strategy and assume competition is always possible.
- 05
Epic, while a major player, isn't the dominant threat some founders perceive in all healthcare segments. Many specialty care areas use diverse EMRs, creating market fragmentation that can act as a barrier to entry for large systems and opportunities for specialized vendors.
Read the full write-up on Substack.
